 Applied Therapeutics NASDAQ:APLT has received a consensus rating of Buy from the eight ratings firms that are currently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month price target among brokerages that have issued a report ... 